Tumor Biomarker Test Market, Global Outlook and Forecast 2023-2030
This report aims to provide a comprehensive presentation of the global market for Tumor Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Biomarker Test. This report contains market size and forecasts of Tumor Biomarker Test in global, including the following market information:
Global Tumor Biomarker Test Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Tumor Biomarker Test market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prostate Specific Antigen Tests Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tumor Biomarker Test include Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc. and Illumina Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Biomarker Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Biomarker Test Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Tumor Biomarker Test Market Segment Percentages, by Type, 2022 (%)
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Global Tumor Biomarker Test Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Tumor Biomarker Test Market Segment Percentages, by Application, 2022 (%)
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
Global Tumor Biomarker Test Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Tumor Biomarker Test Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Biomarker Test revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tumor Biomarker Test revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Biomarker Test, market overview.
Chapter 2: Global Tumor Biomarker Test market size in revenue.
Chapter 3: Detailed analysis of Tumor Biomarker Test company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Biomarker Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
